keyboard_arrow_up

Pheochromocytoma Therapeutic Drugs and Companies Pipeline Review H1 2015

RnRMarketResearch.com adds “Pheochromocytoma – Pipeline Review, H1 2015” to its store.

The report “Pheochromocytoma – Pipeline Review, H1 2015” provides comparative analysis on the therapeutic development for Pheochromocytoma. The report strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Complete report on H1 2015 pipeline review of Pheochromocytoma with 19 market data tables and 13 figures, spread across 64 pages is available at http://www.rnrmarketresearch.com/pheochromocytoma-pipeline-review-h1-2015-market-report.html .

Companies discussed in this Pheochromocytoma – Pipeline Review, H1 2015 report include AstraZeneca PLC, Exelixis, Inc., MediaPharma s.r.l., Pfizer Inc., Progenics Pharmaceuticals, Inc.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Drug Profiles mentioned in this report are cabozantinib s-malate, iobenguane sulfate I 131, MPHE-001B, S-43126, sunitinib malate, vandetanib. Order a purchase copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=382516 . (This is a premium report priced at US$2000 for a single user License.)

Featured News & Press Releases cover by this report includes: Mar 02, 2015: Progenics Pharmaceuticals Announces Presentation at ENDO 2015; Jan 23, 2015: Progenics Pharmaceuticals Relaunches Pivotal Trial of AZEDRA in Pheochromocytoma; Sep 22, 2014: Progenics Pharmaceuticals Presents Long Term Follow-Up of Pivotal Phase 2 Trial of Azedra in Malignant Pheochromocytoma; Apr 01, 2014: Progenics Pharmaceuticals and Centre for Probe Development and Commercialization Announce Agreement to Manufacture Targeted Radiotherapeutic Candidate for Ultra-Orphan Indications; Nov 25, 2013: Progenics Pharmaceuticals Relaunching Registrational Trial of Azedra to Treat Pheochromocytomas.

List of Tables

Number of Products under Development for Pheochromocytoma, H1 2015 7

Number of Products under Development for Pheochromocytoma - Comparative Analysis, H1 2015 8

Number of Products under Development by Companies, H1 2015 9

Number of Products under Investigation by Universities/Institutes, H1 2015 10

Comparative Analysis by Clinical Stage Development, H1 2015 11

Comparative Analysis by Early Stage Development, H1 2015 12

Products under Development by Companies, H1 2015 13

Products under Investigation by Universities/Institutes, H1 2015 14

Pheochromocytoma - Pipeline by AstraZeneca PLC, H1 2015 15

Pheochromocytoma - Pipeline by Exelixis, Inc., H1 2015 16

Pheochromocytoma - Pipeline by MediaPharma s.r.l., H1 2015 17

Pheochromocytoma - Pipeline by Pfizer Inc., H1 2015 18

Pheochromocytoma - Pipeline by Progenics Pharmaceuticals, Inc., H1 2015 19

Assessment by Monotherapy Products, H1 2015 20

Number of Products by Stage and Target, H1 2015 22

Number of Products by Stage and Mechanism of Action, H1 2015 24

Number of Products by Stage and Route of Administration, H1 2015 26

Number of Products by Stage and Molecule Type, H1 2015 27

Pheochromocytoma Therapeutics - Recent Pipeline Updates, H1 2015 45

List of Figures

Number of Products under Development for Pheochromocytoma, H1 2015 7

Number of Products under Development for Pheochromocytoma - Comparative Analysis, H1 2015 8

Number of Products under Development by Companies, H1 2015 9

Comparative Analysis by Clinical Stage Development, H1 2015 11

Comparative Analysis by Early Stage Products, H1 2015 12

Assessment by Monotherapy Products, H1 2015 20

Number of Products by Top 10 Targets, H1 2015 21

Number of Products by Stage and Top 10 Targets, H1 2015 21

Number of Products by Top 10 Mechanism of Actions, H1 2015 23

Number of Products by Stage and Top 10 Mechanism of Actions, H1 2015 24

Number of Products by Top 10 Routes of Administration, H1 2015 25

Number of Products by Stage and Top 10 Routes of Administration, H1 2015 26

Number of Products by Stage and Top 10 Molecule Types, H1 2015 27

Explore more reports on Allergy therapeutics industry at http://www.rnrmarketresearch.com/reports/life-sciences/pharmaceuticals/therapeutics/allergy-therapeutics .

About Us:

RnRMarketResearch.com is an online database of market research reports offer in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.